3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Pancreatic Adenocarcinoma
1
Pain, Postoperative
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Hypotension
1
Cognitive Dysfunction
1
Chronic Pain
1
Breast Carcinoma In Situ
1
Agnosia
1
Acute Pain
1
Interventions
Gemcitabine
16
Mitomycin
10
Docetaxel
6
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Anesthesia, General
×
1 year
×
Clear all
No trials found.